The Role of Millrenone in Patients with Pulmonary Hypertension and Other Forms of Shock

This chapter explores the role of millrenone, a selective phosphodiesterase 3 inhibitor, in vasodilation for patients with pulmonary hypertension and shock. The speaker discusses its potential long-acting effects, preference for using buremin in certain cases, limitations due to tachycardias, and the possibility of inhaled millrenone for patients with low blood pressure.